湖南赛隆药业有限公司赢得赖氨匹林化学原料药上市恳求批准奉告书

赛隆药业（002898）于5月24日发布公告称，赛隆药业集团股份有限公司（以下简称“公司”）全资子公司湖南赛隆药业有限公司于近日赢得国度药品监督贬责局核准签发的赖氨匹林《化学原料药上市恳求批准奉告书》。

赖氨匹林主要适当症为：用于调整发烧及轻、中度痛苦。

潇湘晨报详尽

爆料、维权通谈：诈欺商场下载“晨视频”客户端，搜索“帮手”一键直达“晨意帮手”平台；或拨打热线0731-85571188。政企推行处事专席19176699651。

举报/响应","del":0,"gnid":"9dfbf43e8607bd04f","img_data":[{"flag":2,"img":[{"desc":"","height":"385","title":"","url":"http://p2.img.360kuai.com/t01494efa2e2f95da16.jpg","width":"889"}]}],"original":0,"pat":"art_src_1,fts0,sts0","powerby":"cache","pub_time":1716538621000,"pure":"","rawurl":"http://zm.news.so.com/5f86090730e8f7e896fc379cfa4dd2a9","redirect":0,"rptid":"4283c74c32b07276","rss_ext":[],"s":"t","src":"潇湘晨报","tag":[],"title":"湖南赛隆药业有限公司赢得赖氨匹林化学原料药上市恳求批准奉告书","type":"zmt","wapurl":"http://zm.news.so.com/5f86090730e8f7e896fc379cfa4dd2a9","ytag":"健康:健康行业资讯:病院","zmt":{"brand":{},"cert":"潇湘晨报官方账号","desc":"影响湖南 湖南影响","fans_num":104834,"id":"3173808547","is_brand":"0","name":"潇湘晨报","new_verify":"4","pic":"https://p0.img.360kuai.com/t0117ad510b9ac12d2f.jpg","real":1,"textimg":"https://p9.img.360kuai.com/bl/0_3/t017c4d51e87f46986f.png","verify":"0"},"zmt_status":0}","errmsg":"","errno":0}